Synergistic Effects
Synergistic Effects - Related Videos
01:33
Synergistic Photobiomodulation with a Dual-Wavelength Laser in an In Vitro Disease Model
0 Views •
2025
Divide the transwell system into five groups that undergo various treatments.The first group serves as the control and consists of a co-culture of neuroblastoma and microglia cells.In the second group, treat the co-culturer with fibrillar β-amyloid (fAβ) alone. fAβ induces damage in neuroblastoma cells.In the third group, treat neuroblastoma cells with an 808-nanometer laser, then co-culture them with untreated microglia.The laser reduces oxidative stress, improving neuronal survival.In the...
02:25
Synergistic Effect of Intracranial and Intraperitoneal Delivery of Analgesic Drugs on Thermal Pain Response in a Rat
0 Views •
2025
Source: Martinez, E., et al. Intracranial Pharmacotherapy and Pain Assays in Rodents. J. Vis. Exp. (2019).This video demonstrates the intracranial administration of an analgesic drug in an anesthetized rat with a pre-implanted guide cannula in the prefrontal cortex. An additional analgesic drug is co-administered intraperitoneally. Following recovery, the rat’s thermal pain response is assessed using Hargreave’s apparatus, where paw withdrawal latency is measured to evaluate the analgesic...
05:57
The Synergistic Effect of Visible Light and Gentamycin on Pseudomona aeruginosa Microorganisms
0 Views •
Cited by 8 •
2013
We show that a developed biomedical device involving continuous or pulsed visible laser based treatment that is combined with antibiotic treatment (gentamycin), results in a statistically significant synergistic effect leading to a reduction in the viability of P. aeruginosa PAO1, by 8 log's compared to antibiotic treatment alone.
01:23
Synergistic Antimicrobial Effect of Membrane-Targeting Compounds on Antibiotic-Resistant Bacteria
0 Views •
2026
Take suspensions of an antibiotic-resistant strain of a pathogenic bacterium.Treat one suspension with a short, membrane-disrupting antibiotic compound and the other with both the short compound and a longer, membrane-intercalating compound.Incubate both suspensions with agitation. These compounds mimic the lipid bilayer structure, enabling their spontaneous insertion into bacterial membranes.The short compound spans only part of the membrane’s thickness, creating a structural mismatch. This...
02:19
Buffer Effectiveness
0 Views •
2020
Buffer solutions do not have an unlimited capacity to keep the pH relatively constant . Instead, the ability of a buffer solution to resist changes in pH relies on the presence of appreciable amounts of its conjugate weak acid-base pair. When enough strong acid or base is added to substantially lower the concentration of either member of the buffer pair, the buffering action within the solution is compromised. The buffer capacity is the amount of acid or base that can be added to a given volume...
FAQs
Complementary pathways can amplify treatment activity when separate interventions influence different biological routes that converge on the same disease process. This interaction may produce a stronger therapeutic response than either intervention alone. Understanding which pathways contribute helps researchers explain why a combination works and may support more targeted strategies for diseases involving multiple biological mechanisms.
A stronger combined response does not automatically indicate a clinically useful treatment. Researchers need to determine whether the interaction changes as doses vary and whether increased activity is accompanied by greater toxicity. These assessments clarify whether the combination can improve therapeutic effects safely, maintain benefit at lower doses, or create unacceptable risks.
The key comparison is between the observed outcome from a combined treatment and the outcome expected from the separate effects of its components. If the combination performs better than that expectation, the interaction supports a synergistic interpretation. This comparison prevents researchers from labeling every improved response as synergy when the result may simply reflect individual treatment activity.
Researchers compare outcomes from the combined intervention with outcomes produced by each intervention separately and with the response expected from those individual effects. They also examine dose dependence and monitor toxicity during the comparison. This workflow helps determine whether the observed benefit reflects a meaningful interaction rather than the effect of only one component.
Combination strategies become especially relevant when a disease process may be influenced through complementary biological mechanisms or when one treatment alone provides insufficient activity. Researchers can investigate whether pairing interventions increases therapeutic efficacy or permits lower doses. The approach is intended to improve treatment strategies while preserving attention to toxicity and overall clinical suitability.
Studies of these interactions can reveal whether combining drugs or treatments produces greater therapeutic activity, whether the benefit depends on dose, and whether toxicity changes with the combination. Such findings may guide the selection of treatment pairs, support dose planning, and inform development of strategies designed to address complex diseases more effectively.